Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Philip Bedford"'
Flooding is a major source of concern for Texas’ coastal communities. It affects the quality of infrastructure, the lives of citizens, and the ecological systems upon which coastal communities in Texas rely. To plan for and mitigate the impacts of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f1ceb5e9a775ad246abe57513f475cd
https://doi.org/10.37419/eenrs.mitigatingfloodimpactstx
https://doi.org/10.37419/eenrs.mitigatingfloodimpactstx
Publikováno v:
Human Vaccines & Immunotherapeutics. 8:1109-1118
This double-blind, randomized study evaluated the immunogenicity and safety of three production lots of the fully liquid combination DTwP-Hep-Hib vaccine, Quinvaxem (®) (Crucell, The Netherlands) in 360 healthy infants aged 42-64 d old given at 6, 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb5363f382a6081d16ab781efd0ff86
https://doi.org/10.4161/hv.21095
https://doi.org/10.4161/hv.21095
Autor:
Scott Kitchener, Jean Lang, Xiaochu Duan, Marie-Jose Quentin-Millet, Philip Bedford, Richard A. Nichols, Thomas H. Ermak, Remi Forrat, Farshad Guirakhoo, Karen McCarthy, Dennis Morrison, Thomas P. Monath, Niranjan Kanesa-thasan, Sutee Yoksan
Publikováno v:
Human Vaccines. 2:60-67
A randomized double-blind Phase I Trial was conducted to evaluate safety, tolerability, and immunogenicity of a yellow fever (YF)-dengue 2 (DEN2) chimera (ChimeriVax-DEN2) in comparison to that of YF vaccine (YF-VAX). Forty-two healthy YF naive adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9503ee9b1b41469e824859a2aad8b655
https://doi.org/10.4161/hv.2.2.2555
https://doi.org/10.4161/hv.2.2.2555
Autor:
Martin S. Cetron, W. Tad Archambault, Thomas P. Monath, Philip Bedford, Richard Nichols, Leisa H. Weld, Karen McCarthy
Publikováno v:
Human Vaccines. 1:207-214
The incidence of serious and severe multisystem adverse events (AEs) following yellow fever (YF) 17D vaccine is higher in persons of advanced age. One hypothesis for the occurrence of these AEs in the elderly is immunological senescence and a reduced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c98e33fc4e7df920b1ab22f68f434c8
https://doi.org/10.4161/hv.1.5.2221
https://doi.org/10.4161/hv.1.5.2221
Autor:
Scott Kitchener, Philip Bedford, Giovanna Pastor-Cauna, Karen McCarthy, Christian T. Bautista, Richard A. Nichols, Vivian E. Belmusto-Worn, James P. Burans, Alan J. Magill, Billey K. Samame, Jose L. Sanchez, Victor Alberto Laguna-Torres, Maria E. Baldeon, James G. Olson, Thomas P. Monath, Carlos Echevarria
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 72:189-197
We conducted a randomized, double-blind, phase III yellow fever (YF) vaccine trial among 1,107 healthy children in Sullana in northern Peru. The safety and efficacy (by measurement of geometric mean neutralizing antibody titer responses) were determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32a3b4f219d2b51b334d0d9e46888af
https://doi.org/10.4269/ajtmh.2005.72.189
https://doi.org/10.4269/ajtmh.2005.72.189
Autor:
Thomas P. Monath, Philip Bedford, Niranjan Kanesa-thasan, Seth Shapiro, Karen McCarthy, Alison Deary, Danell Mathis, Chuck Miller, Richard A. Nichols, Casey Johnson
Publikováno v:
Human Vaccines. 1:24-29
Two subjects developed marked elevations in creatine kinase and other serum enzymes associated with mild myalgia during a randomized, double-blind, controlled Phase 1 clinical trial of an investigational live, attenuated vaccine against West Nile vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f273908b23a477ba876e057cfcd4f5b
https://doi.org/10.4161/hv.1.1.1324
https://doi.org/10.4161/hv.1.1.1324
Autor:
Farshad, Guirakhoo, Scott, Kitchener, Dennis, Morrison, Remi, Forrat, Karen, McCarthy, Richard, Nichols, Sutee, Yoksan, Xiaochu, Duan, Thomas H, Ermak, Niranjan, Kanesa-Thasan, Philip, Bedford, Jean, Lang, Marie-Jose, Quentin-Millet, Thomas P, Monath
Publikováno v:
Human vaccines. 2(2)
A randomized double-blind Phase I Trial was conducted to evaluate safety, tolerability, and immunogenicity of a yellow fever (YF)-dengue 2 (DEN2) chimera (ChimeriVax-DEN2) in comparison to that of YF vaccine (YF-VAX). Forty-two healthy YF naïve adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f78bf44e35af624701ae47996c746bd
https://pubmed.ncbi.nlm.nih.gov/17012873
https://pubmed.ncbi.nlm.nih.gov/17012873
Autor:
Thomas H. Ermak, Gwendolyn A. Myers, Philip Bedford, Jian Liu, Sharone Green, Jeffrey S. Kennedy, Karen McCarthy, Casey Johnson, Francis A. Ennis, Farshad Guirakhoo, Juan Pablo Arroyo, Thomas P. Monath, Niranjan Kanesa-thasan, Alison Deary, Richard Nichols, Sunheang Shin
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 103(17)
West Nile (WN) virus is an important cause of febrile exanthem and encephalitis. Since it invaded the U.S. in 1999, >19,000 human cases have been reported. The threat of continued epidemics has spurred efforts to develop vaccines. ChimeriVax-WN02 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f02dacad0932a6d8e34683ddf3dd49
https://pubmed.ncbi.nlm.nih.gov/16617103
https://pubmed.ncbi.nlm.nih.gov/16617103
Autor:
David A. Sack, Philip Bedford, Cynthia K. Lee, Jennifer L. Kyle, Joseph G. Gomes, Arthur K. Turner, Fred Cassels, Michael J. Darsley, Fayette Engstrom, H. Sunny Chang, A. Louis Bourgeois, Janet Shimko, Eric Hall, Roger Randall, Robin McKenzie
Enterotoxigenic Escherichia coli (ETEC) are a significant cause of diarrhea in developing countries, resulting in 400,000 deaths annually in children under the age of 5 years (27). In addition, ETEC are the most common cause of traveler's diarrhea. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10969624f3a098cd53e14028c604244d
https://europepmc.org/articles/PMC1360313/
https://europepmc.org/articles/PMC1360313/
Autor:
August L. Bourgeois, N. Diaz, C. Howard, Colleen Carpenter, H.S. Chang, C. Gewert, Nicola Thomas, Philip Bedford, Frederick J. Cassels, Robin McKenzie, Michael J. Darsley, Eric Hall, David A. Sack, R. B. Sack, Roger Randall, G. Gomes
Publikováno v:
Vaccine. 24(18)
In the present study we compared the ELISPOT and antibody in lymphocyte supernatants (ALS) assays as surrogate measures of mucosal immunity. In separate studies, 20 inpatient volunteers received oral doses of 6 x 10(8) or 4 x 10(9)cfu of ETEC strain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6e5eae0baf76ce091ec6f35b1db637
https://pubmed.ncbi.nlm.nih.gov/16153753
https://pubmed.ncbi.nlm.nih.gov/16153753